DARE 204/214 Investigational injectable etonogestrel formulations designed for six or twelve months of reversible contraception, with Phase 1 preparation listed.
Visit productCosigns Received
Be the first Cosign
Put your name behind DARE 204/214.
Add it to your Products I use list and share why you use it.